Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 37, 2022 - Issue 1
Research Papers
Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors
Tony Eight Lina Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan;b Master Program in Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
https://orcid.org/0000-0002-6267-0224View further author information
https://orcid.org/0000-0002-6267-0224View further author information, Li-Chin Sungc Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan;d Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwanhttps://orcid.org/0000-0001-6292-7117View further author information
https://orcid.org/0000-0001-6292-7117View further author information, Min-Wu Chaoe School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwanhttps://orcid.org/0000-0002-9122-3415View further author information
https://orcid.org/0000-0002-9122-3415View further author information, , , , Jui-Hua Hsiehh Division of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, USAhttps://orcid.org/0000-0003-1620-1571View further author information
https://orcid.org/0000-0003-1620-1571View further author information, Chia-Ron Yange School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwanhttps://orcid.org/0000-0001-5990-1346View further author information
https://orcid.org/0000-0001-5990-1346View further author information, Hsueh-Yun Leef School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwanhttps://orcid.org/0000-0001-6683-0726View further author information
https://orcid.org/0000-0001-6683-0726View further author information, Er-Chieh Chof School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan;i Master Program in Clinical Genomics and Proteomics, College of Pharmacy, Taipei Medical University, Taipei, Taiwan;j Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, ROCCorrespondence[email protected]
https://orcid.org/0000-0002-0921-4916View further author information
https://orcid.org/0000-0002-0921-4916View further author information & Kai-Cheng Hsua Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan;j Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, ROC;k Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, ROC;l TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan;m TMU Research Center of Drug Discovery, Taipei Medical University, Taipei, Taiwan;n Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, TaiwanCorrespondence[email protected]
https://orcid.org/0000-0002-9022-6673View further author information
https://orcid.org/0000-0002-9022-6673View further author information show all